Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trollfors

Showing results (181-190 of 234) with videos related to

Pageof 24
Sort By:
The Pediatric Infectious Disease Journal|May 7, 2005
Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccineBo A Claesson, Birger Trollfors, Teresa Lagergård, et al.
European Journal of Pediatrics|October 27, 2005
Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster doseBirger Trollfors, Nina Knutsson, John Taranger, et al.
Advances in Experimental Medicine and Biology|January 16, 1999
Immunity to pertussis. Not all virulence factors are protective antigensJ B Robbins, R Schneerson, D A Bryla, et al.
The Journal of Pediatrics|June 1, 1990
Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenB A Claesson, R Schneerson, B Trollfors, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assayG Zackrisson, F Arminjon, I Krantz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 5, 2007
Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitisC Welinder-Olsson, L Dotevall, H Hogevik, et al.
The Pediatric Infectious Disease Journal|January 1, 1994
Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infantsJ Isacson, B Trollfors, J Taranger, et al.
BMC Infectious Diseases|November 11, 2015
Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988Margrét Johansson Gudjónsdóttir, Elisabet Hentz, Stefan Berg, et al.
Pediatrics|December 4, 2001
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccineJ Taranger, B Trollfors, E Bergfors, et al.
European Journal of Pediatrics|April 16, 1998
Antibodies to group B streptococci in neonates and infantsS Berg, S Kasvi, B Trollfors, et al.
Pageof 24

Showing results (181-190 of 234) with videos related to

Sort By:
Pageof 24
The Pediatric Infectious Disease Journal|May 7, 2005
Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccineBo A Claesson, Birger Trollfors, Teresa Lagergård, et al.
European Journal of Pediatrics|October 27, 2005
Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster doseBirger Trollfors, Nina Knutsson, John Taranger, et al.
Advances in Experimental Medicine and Biology|January 16, 1999
Immunity to pertussis. Not all virulence factors are protective antigensJ B Robbins, R Schneerson, D A Bryla, et al.
The Journal of Pediatrics|June 1, 1990
Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old childrenB A Claesson, R Schneerson, B Trollfors, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assayG Zackrisson, F Arminjon, I Krantz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 5, 2007
Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitisC Welinder-Olsson, L Dotevall, H Hogevik, et al.
The Pediatric Infectious Disease Journal|January 1, 1994
Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infantsJ Isacson, B Trollfors, J Taranger, et al.
BMC Infectious Diseases|November 11, 2015
Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988Margrét Johansson Gudjónsdóttir, Elisabet Hentz, Stefan Berg, et al.
Pediatrics|December 4, 2001
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccineJ Taranger, B Trollfors, E Bergfors, et al.
European Journal of Pediatrics|April 16, 1998
Antibodies to group B streptococci in neonates and infantsS Berg, S Kasvi, B Trollfors, et al.
Pageof 24